Enlivex Therapeutics Ltd. buy melinda
Start price
27.01.17
/
50%
€47.63
Target price
27.07.17
€72.16
Performance (%)
-53.77%
End price
27.07.17
€22.02
Summary
This prediction ended on 27.07.17 with a price of €22.02. Massive losses of -53.77% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | 10.156% | 10.156% | -36.486% | -81.914% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Phase LE2 / 02/2017
folgen
(Laufzeit überschritten)
Stopped prediction by melinda for Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€21.20
25.10.17
25.10.17
€22.40
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€19.12
25.10.17
25.10.17
€20.20
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€14.65
26.09.17
26.09.17
€18.04
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.24
26.09.17
26.09.17
€20.00
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€185.81
14.10.15
14.10.15
€234.52
14.04.16
14.04.16
-54.95%
14.04.16
14.04.16